Article: New leaders at FDA could slow device approvals; A clinical trial executive says resignation of a review center head appears to indicate a desire for increased caution.(BUSINESS)

Byline: JANET MOORE; STAFF WRITER

Linda Alexander, chief executive and founder of Golden Valley-based Alquest Inc., has some definite opinions about the machinations at the Food and Drug Administration (FDA).

No surprise -- Alquest is a contract research organization that specializes in conducting medical-device clinical trials and other support processes that help medical technology companies negotiate the FDA's often confounding approval process.

The Star Tribune asked Alexander about the latest turn at the FDA last week -- the abrupt resignation of Dr. Daniel Schultz, who headed the agency's Center for Devices and Radiological Health for the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!